238 related articles for article (PubMed ID: 22244588)
21. Synthesis and biological evaluation of 4β-acrylamidopodophyllotoxin congeners as DNA damaging agents.
Kamal A; Suresh P; Janaki Ramaiah M; Mallareddy A; Kumar BA; Raju P; Vinay Gopal J; Pushpavalli SN; Lavanya A; Sarma P; Pal-Bhadra M
Bioorg Med Chem; 2011 Aug; 19(15):4589-600. PubMed ID: 21737288
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus sylvestris: Induction of G2/M cell cycle arrest and caspase-dependent apoptosis.
Yong Y; Shin SY; Lee YH; Lim Y
Bioorg Med Chem Lett; 2009 Aug; 19(15):4367-71. PubMed ID: 19501508
[TBL] [Abstract][Full Text] [Related]
24. Quinazolino linked 4β-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation.
Kamal A; Tamboli JR; Ramaiah MJ; Adil SF; Pushpavalli SN; Ganesh R; Sarma P; Bhadra U; Pal-Bhadra M
Bioorg Med Chem; 2013 Nov; 21(21):6414-26. PubMed ID: 24055291
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives.
Zhang FM; Yao XJ; Tian X; Tu YQ
Molecules; 2006 Nov; 11(11):849-57. PubMed ID: 18007391
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4'-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors.
Zhao Y; Ge CW; Wu ZH; Wang CN; Fang JH; Zhu L
Eur J Med Chem; 2011 Mar; 46(3):901-6. PubMed ID: 21277655
[TBL] [Abstract][Full Text] [Related]
28. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
29. Alkyl and carboxylalkyl esters of 4'-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity.
You YJ; Kim Y; Nam NH; Bang SC; Ahn BZ
Eur J Med Chem; 2004 Feb; 39(2):189-93. PubMed ID: 14987827
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate activated protein kinase and induction of apoptosis.
Tripodi F; Pagliarin R; Fumagalli G; Bigi A; Fusi P; Orsini F; Frattini M; Coccetti P
J Med Chem; 2012 Mar; 55(5):2112-24. PubMed ID: 22329561
[TBL] [Abstract][Full Text] [Related]
31. Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin.
Kim KY; Cho HJ; Yu SN; Kim SH; Yu HS; Park YM; Mirkheshti N; Kim SY; Song CS; Chatterjee B; Ahn SC
J Cell Biochem; 2013 May; 114(5):1124-34. PubMed ID: 23192945
[TBL] [Abstract][Full Text] [Related]
32. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells.
Qi YL; Liao F; Zhao CQ; Lin YD; Zuo MX
Acta Pharmacol Sin; 2005 Aug; 26(8):1000-8. PubMed ID: 16038635
[TBL] [Abstract][Full Text] [Related]
34. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of 4β-alkylamidochalcone and 4β-cinnamido linked podophyllotoxins as apoptotic inducing agents.
Kamal A; Mallareddy A; Suresh P; Lakshma Nayak V; Shetti RV; Sankara Rao N; Tamboli JR; Shaik TB; Vishnuvardhan MV; Ramakrishna S
Eur J Med Chem; 2012 Jan; 47(1):530-45. PubMed ID: 22136907
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
38. Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase.
Kashyap M; Das D; Preet R; Mohapatra P; Satapathy SR; Siddharth S; Kundu CN; Guchhait SK
Bioorg Med Chem Lett; 2012 Apr; 22(7):2474-9. PubMed ID: 22381050
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
40. Conjugates of podophyllotoxin and norcantharidin as dual inhibitors of topoisomeraseⅡ and protein phosphatase 2A.
Tang ZB; Chen YZ; Zhao J; Guan XW; Bo YX; Chen SW; Hui L
Eur J Med Chem; 2016 Nov; 123():568-576. PubMed ID: 27517805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
